Thermo Fisher Scientific analyzed approximately 5,500 research samples from the Parkinson's Precision Medicine Initiative using Olink™ Explore HT technology to create a large-scale proteomics resource available to researchers worldwide.

Public source

Publisher name

Public post

Parkinson's disease is incredibly complex, and understanding that complexity requires looking beyond clinical symptoms to the underlying biology. That's what makes this…

Log in to read the full post

Company

Thermo Fisher Scientific

Industry
Biotechnology Research
Location
Waltham, US
Company size
10,001+ employees

About Thermo Fisher Scientific

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

See more

Latest activity

220 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.